Trial intelligence / Profile preview

Buccal vs IV Prochlorperazine for Migraine

NCT02779959Phase 3Unknown

Sponsor
The Lundquist Institute
Start
Apr 2016
Primary completion
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of prochlorperazine in migraine, sponsored by The Lundquist Institute. Status: unknown.

02

Drugs

prochlorperazine
03

Conditions

migraine

Beyond the preview

Go deeper on NCT02779959.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02779959.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call